Vivos Therapeutics, Inc.
VVOS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,399 | -$5,013 | -$3,864 | -$2,827 |
| Dep. & Amort. | $384 | $306 | $177 | $144 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $55 | $242 | $317 | $57 |
| Change in WC | -$445 | $871 | -$426 | -$319 |
| Other Non-Cash | $1,244 | $100 | $0 | $5 |
| Operating Cash Flow | -$4,161 | -$3,494 | -$3,796 | -$2,940 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $893 | -$771 | -$122 | -$165 |
| Net Acquisitions | $5,135 | -$5,135 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,945 | $0 | $0 | $0 |
| Investing Cash Flow | $83 | -$5,906 | -$122 | -$165 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $9,642 | $0 | $0 |
| Stock Issued | $957 | $1,818 | $0 | $3,500 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,763 | $0 | $0 | -$446 |
| Financing Cash Flow | $2,763 | $11,460 | $0 | $3,054 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,315 | $2,060 | -$3,918 | -$51 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,402 | $2,342 | $6,260 | $6,311 |
| End Cash | $3,087 | $4,402 | $2,342 | $6,260 |
| Free Cash Flow | -$3,268 | -$4,265 | -$3,796 | -$3,105 |